Skip to main content

Table 2 Indication to IMPELLA , MCS-related management and outcomes

From: The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience

Patient ID

Indication to implantation

Rationale for impella’s implantation

Devices implanted

Hemolysis

Anticoagulation

Major bleeding

Outcome

IMP1

CSMI (STEMI)

Circulatory support, LV venting

IMPELLA 2.5, IABP

No

UFH 25 U/ml (purge fluid)

No

LVAD

IMP2

Cardiogenic shock (arrhytmia)

LV venting during ECMO in severe AI

IMPELLA 2.5, VA ECMO

No

UFH 25 U/ml (purge fluid)

No

Bridge to BIVAD and HTX

IMP3

CSMI (STEMI)

Coronary perfusion, LV venting during ECMO

IMPELLA 2.5, VA ECMO

No

IV bivalirudin

No

Organ donor (brain death)

IMP4

Cardiogenic shock

LV venting during ECMO

IMPELLA 2.5, VA ECMO

No

IV bivalirudin

No

Recovery

IMP5

Postcardiotomic cardiogenic shock (Sleeve procedure)

Coronary perfusion, LV venting

IMPELLA 2.5, VA ECMO, IABP

Yes

IV bivalirudin

Yes

Bridge to HTX

IMP6

CSMI (STEMI)

Coronary perfusion, circulatory support

IMPELLA 2.5, IABP

No

IV bivalirudin

No

Recovery

IMP7

Cardiogenic shock following percutaneous VT ablation

Circulatory support, LV venting

IMPELLA 2.5

No

IV bivalirudin

No

Recovery

IMP8

Cardiogenic shock (coronary ischemia)

Circulatory support

IMPELLA CP, IABP

No

UFH 50 U/ml (purge fluid)

Yes

Death (MOF-withdrawal of care)

IMP9

CSMI (STEMI)

Coronary perfusion, LV venting

IMPELLA 2.5, VA ECMO

No

-

No

Death (MOF-withdrawal of care)

IMP10

CSMI (STEMI)

Coronary perfusion, circulatory support, LV venting

IMPELLA 2.5, IABP

No

UFH 50 U/ml (purge fluid)

No

Recovery

IMP11

CSMI (STEMI)

Coronary perfusion, circulatory support

IMPELLA 2.5, IABP

No

UFH 50 U/ml (purge fluid)

No

Recovery

IMP12

Postcardiotomic cardiogenic shock (LV aneurismectomy )

LV venting

IMPELLA 2.5, VA ECMO

Yes

IV bivalirudin

Yes

Death (progressive cardiogenic shock)

IMP13

Postcardiotomic cardiogenic shock (CABG)

Coronary perfusion, circulatory support

IMPELLA CP, IABP

No

UFH 50 U/ml (purge fluid)

No

Recovery

IMP14

CSMI (STEMI)

Coronary perfusion, LV venting

IMPELLA 2.5, VA ECMO

Yes

IV bivalirudin

No

Death (MOF-withdrawal of care)

IMP15

Postcardiotomic cardiogenic shock (Mitral plasty)

Coronary perfusion, circulatory support, LV venting

IMPELLA 2.5, VA ECMO, IABP

No

IV bivalirudin

No

Recovery

IMP 16

CSMI (STEMI)

Coronary perfusion, circulatory support

IMPELLA 2.5, IABP

No

IV bivalirudin

No

Recovery

IMP 17

Cardiogenic shock (cronic myocarditis)

Coronary perfusion, circulatory support

IMPELLA 2.5, IABP

Yes

IV bivalirudin

No

Recovery

IMP18

Postcardiotomic cardiogenic shock (CABG)

LV venting during VA ECMO

IMPELLA 2.5, VA ECMO, IABP

No

UFH 25 U/ml (purge fluid)

Yes

Recovery

IMP 19

Cardiogenic shock (arrhytmia)

Coronary perfusion, circulatory support, severe AI

IMPELLA 2.5

No

IV bivalirudin

No

Recovery

IMP 20

Cardiogenic shock (coronary artery disease)

Coronary perfusion, circulatory support

IMPELLA CP

No

IV bivalirudin

No

Recovery

IMP 21

Cardiogenic shock (chronic heart failure, multiple valvulopathy)

LV venting during VA ECMO

IMPELLA 2.5, VA ECMO, IABP

Yes

IV bivalirudin, UFH 25 U/ml (purge fluid)

No

Death (MOF-withdrawal of care)

IMP 22

CSMI (STEMI)

Coronary perfusion, circulatory support, moderate AI

IMPELLA CP

Yes

UFH 25 U/ml (purge fluid)

No

Recovery

  1. CSMI – cardiogenic shock myocardial infarction; STEMI – ST elevation myocardial infarction; VT – ventricular tachycardia; LV – left ventricle; VA ECMO – venoarterial extracorporeal membrane oxygenation; IABP – intraortic balloon pump; IV – intravenous; UFH – unfractionated heparin; VAD–ventricular assit device; HTX – heart transplantion